20619446

Source:http://linkedlifedata.com/resource/pubmed/id/20619446

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017262, umls-concept:C0041904, umls-concept:C0078193, umls-concept:C0162493, umls-concept:C0185117, umls-concept:C0205179, umls-concept:C0440743, umls-concept:C1140680, umls-concept:C1306673, umls-concept:C2911684
pubmed:issue	1
pubmed:dateCreated	2010-9-13
pubmed:abstractText	The purpose of this study is to examine the role of versican (VCAN) in advanced stage serous ovarian cancer by investigating its expression, its function, and its correlation with clinical outcomes.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/P50 CA083639-02, http://linkedlifedata.com/resource/pubmed/grant/P50CA083639, http://linkedlifedata.com/resource/pubmed/grant/P50CA165009, http://linkedlifedata.com/resource/pubmed/grant/R01 CA133057-01A1, http://linkedlifedata.com/resource/pubmed/grant/R01 CA133057-02, http://linkedlifedata.com/resource/pubmed/grant/R01CA133057, http://linkedlifedata.com/resource/pubmed/grant/R33CA103595
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/VCAN protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Versicans
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1095-6859
pubmed:author	pubmed-author:AlbitarLinaL, pubmed-author:BerkowitzRoss SRS, pubmed-author:BirrerMichael JMJ, pubmed-author:GhoshSueS, pubmed-author:LeBaronRichardR, pubmed-author:MokSamuel CSC, pubmed-author:SamimiGoliG, pubmed-author:WelchWilliam RWR
pubmed:copyrightInfo	Copyright © 2010 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:volume	119
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	114-20
pubmed:dateRevised	2011-10-3
pubmed:meshHeading	pubmed-meshheading:20619446-Animals, pubmed-meshheading:20619446-CHO Cells, pubmed-meshheading:20619446-Cell Growth Processes, pubmed-meshheading:20619446-Cell Line, Tumor, pubmed-meshheading:20619446-Cricetinae, pubmed-meshheading:20619446-Cricetulus, pubmed-meshheading:20619446-Cystadenocarcinoma, Serous, pubmed-meshheading:20619446-Female, pubmed-meshheading:20619446-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20619446-Humans, pubmed-meshheading:20619446-Immunohistochemistry, pubmed-meshheading:20619446-Neoplasm Invasiveness, pubmed-meshheading:20619446-Neoplasm Staging, pubmed-meshheading:20619446-Neovascularization, Pathologic, pubmed-meshheading:20619446-Ovarian Neoplasms, pubmed-meshheading:20619446-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20619446-Up-Regulation, pubmed-meshheading:20619446-Versicans
pubmed:year	2010
pubmed:articleTitle	Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
pubmed:affiliation	Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural